openPR Logo
Press release

Immunomodulators Market: An Insight on the Important Factors and Trends Influencing the Market by 2026

06-19-2019 09:23 AM CET | Health & Medicine

Press release from: Allied Market Research

Immunomodulators are substances that alter the immune response by decreasing the responsiveness of the immune system to make antibodies or sensitized cells. These cells identify and react with the antigen that instigated their production.

Some of the immunomodulators are corticosteroids, thymosin, cytotoxic agents, and immunoglobulins. Few of the immunomodulators are naturally present in the body, while some of these are obtained from pharmacological preparations.

The key players of the market included in the report are F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., and Biogen Inc.

Pre-Book with 10% Discount at: https://www.alliedmarketresearch.com/checkout-final/2a610b107562686906e9573033e5382b

The major factors that drive the market growth are increasing usage of monoclonal antibodies to treat diseases such as sclerosis, Crohns disease, rheumatoid arthritis & others, and the rising prevalence of cancer. In addition, availability of effective product pipeline of the companies involved in R&D of immunomodulators further fuels the market growth.

However, the presence of stringent regulations involved in the approval procedure for immunomodulator antibodies pose entry difficulties for small-scale manufacturers, less availability of tumor necrosis factor (TNF) inhibitors, and high costs associated with them act as restraints for the market growth.

In addition, rising awareness regarding the availability of such immunomodulators is anticipated to provide lucrative growth opportunities for the market.
The report segments the immunomodulators market based on product, application, and region. Based on product, the market is segmented into immunosuppressants and immunostimulants.

Based on immunosuppressants, the market is segmented into antibodies, calcineurin inhibitors, glucocorticoids, antimetabolites, and others. Based on immunostimulants, the market is segmented into vaccines, antibodies, and others. Based on application, the market is segmented into oncology, respiratory, human immunodeficiency virus (HIV), and others. Regionally, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

• The study provides an in-depth analysis of the immunomodulators market, with current trends and future estimations to elucidate imminent investment pockets.
• It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the market by product type elucidates various forms of available immunomodulators.
• Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.
• By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3838

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1〈855〉550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunomodulators Market: An Insight on the Important Factors and Trends Influencing the Market by 2026 here

News-ID: 1780521 • Views: 116

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Based

Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Hospital-based EMR Market
Electronic medical record (EMR) is a digital version of a paper chart, which contains a patient's medical history. This system is designed to share information with other healthcare providers such as laboratories and specialists. It helps to reduce operational cost such as transcription services and overtime labor expenses. Get Sample PDF of Report@ https://www.alliedmarketresearch.com/request-toc-and-sample/3219 Increase in demand for advanced health monitoring systems drives the growth of the market. In addition, rise in
Plant Based Beverages Market
https://www.qandqmarketresearch.com/reports/7360187/plantbased-beverages-market-87 Plantbased products include plantbased beverages that are further classified into plantbased dairy alternatives, juices, and readytodrink beverages. The plantbased beverages segment is expected to witness a growing CAGR of 6.5% by 2025, owing to the changing eating habits of consumers. Consumers are more conscious about health and wellness than before, and want to consume products that are healthy and natural without compromising on the taste and flavor of the product. Increasing
Plant-based Snacks Market
https://www.qandqmarketresearch.com/reports/7287268/plantbased-snacks-market-24 Plantbased products are those products that are made entirely from plantbased ingredients, and limit or restrict any use of animalbased products. Plantbased products include plantbased snacks, which are further classified into meat alternative snacks, cereal/grainbased snacks, plantbased salted snacks, plantbased snack bars, and fruit and nut snacks. Based on regional segmentation for the plantbased snacks market, North America, Western Europe, and Asia Pacific are estimated to dominate the global plantbased
Account Based Marketing
Today, most of the marketing organizations are moving towards the Account Based Marketing ( ABM ) . The ABM approach has been there for years but the recent technologies available have made this approach scalable and hence more effective and popular. The traditional marketing approach has been around attracting your prospects from a larger pool. The account based marketing is about targeting accounts based on your best business connection. It is
Clinical Nutrition Market 2016: Infant, Milk-based, Soy-based
Latest industry research report on Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others. Rising instances of chronic and lifestyle diseases and increasing population that receives malnutrition treatment are the major factors responsible for driving the growth of the market. Furthermore, rise in global population, disposable